SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-000841
Filing Date
2018-01-11
Accepted
2018-01-11 17:07:09
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2292
  Complete submission text file 0001179110-18-000841.txt   4168
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 973-290-6000
MEDICINES CO /DE (Reporting) CIK: 0001113481 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35405 | Film No.: 18524210
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations